Online tests for early detection of Alzheimer's disease
Official title: TAS Test: Determining the Feasibility and Validity of Online Motor-cognitive Testing for Early Detection of Alzheimer's Disease
Run by University of Tasmania · NCT05194787 · Data updated 2026-11-12
This study is testing a new online test that helps find early signs of Alzheimer's disease in people over 50, allowing them to take it from home.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | University of Tasmania Academic / other |
| Locations | 1 site (Hobart, Tasmania) |
| Status | Recruiting |
| Started | March 5, 2021 |
| Main results expected | December 2025 |
| Study ends | December 2030 |
| Registry record updated | October 30, 2023 |
| Trial ID | NCT05194787 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 50 years old who have normal cognitive function.
✕Probably not a fit
Patients with an established diagnosis of dementia will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop the TAS Test, an innovative online motor-cognitive assessment designed to detect preclinical Alzheimer's disease (pre-AD) up to 10 years before cognitive symptoms manifest. By utilizing hand-movement tests and computer vision technology, participants can self-administer the test from home, making it a scalable solution for early detection. The study will involve two sub-studies: one cross-sectional with 500 participants over 50 years old and a prospective cohort study with 10,000 adults, integrating cognitive data and blood biomarkers to enhance diagnostic accuracy.
Why it matters
Potential benefit: If successful, this approach could enable earlier interventions for Alzheimer's disease, potentially slowing its progression and improving patient outcomes.
How similar studies have gone: Other studies have shown promise in using innovative cognitive assessments for early detection of Alzheimer's, but this specific approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \> 50years old Exclusion Criteria: established diagnosis of dementia
Where it's running
-
University of Tasmania
Hobart, Tasmania, Australia Recruiting
Study contacts
- Principal investigator: A/Prof Bai, PhD MSc — University of Tasmania
- Study coordinator: A/Prof Alty, MD FRACP
- Email: Jane.Alty@utas.edu.au
- Phone: +61 (0)3 36226 4273
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Norms for a Voice-Based Digital Cognitive Test Across Ages
This study tests a voice-enabled digital cognitive test to establish normal scores for adults aged 18–100.
-
Lived Experience Narratives in Dementia
This project tests a digital Online LEND Intervention that shares dementia patients’ and caregivers’ lived experiences to see if it helps wellbeing and connection.
-
Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease
A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.
-
Far-Infrared Therapy for Alzheimer’s Disease Dementia
This trial tests whether a far-infrared radiator can help people with Alzheimer's-related dementia who are on stable dementia medications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.